JPRN-UMIN000018395已完成未知
Prospective comparison of Luseogliflozin and alpha-glucosidase inhibitor on the management of diabetic patients with chronic heart failure and preserved left-ventricular ejection fraction - Prospective comparison of Luseogliflozin and alpha-glucosidase inhibitor on the management of diabetic patients with chronic heart failure and preserved left-ventricular ejection fraction
Cardiovascular Medicine Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences0 个研究点目标入组 190 人开始时间: 2015年9月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 190
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) BNP <35 pg/ml 2) Patients receiving alpha-glucosidase inhibitors, SGLT2 inhibitors, glinides, high-dose sulfonylurea 3) Patients with renal insufficiency (eGFR< 30 ml/min/1.73m2) 4) LVEF<45% 5) Patients with history of severe ketoacidosis, diabetic coma within six months 6) Patients with serious infection and severe trauma, and perioperative patients 7) Type 1 diabetes mellitus 8) Poorly controlled type2 diabetic patients (HbA1c > 9.0%) 9) Uncontrolled hypertensive patients (systolic blood pressure >160mmHg) 10) Patients with history of stroke, myocardial infarction and severe cardiovascular disease with hospitalization within six months 11) Pregnant women and breast-feeding women 12) Patients with allergy for test drugs 13) Patients who is not suitable to this study due to medical reasons
研究者
相似试验
已完成
不适用
Effective and safe examination of Luseogliflozin for patients with fatty liver merger type II diabetes mellitusfatty liver merger type II diabetes mellitusJPRN-UMIN000021087akakinen Clinic40
招募中
不适用
ong-term comparison of luseogliflozin vs sitagliptin for Type 2 diabetes mellitus patients with NASH/NAFLDType 2 diabetes mellitus with NAFLD/NASHNAFLD,NASH,NAFLD/NASH,Type 2 diabetes mellitus,liver fibrosis,fatty liverJPRN-jRCTs031190238Kobayashi Takashi210
招募中
3 期
Eraddication of Helicobacter pylori for quadruple therapy with base of Clarithromycin compared with LevofloxaciHelicobacter pylori infection.Helicobacter pylorB96.81IRCT20171223038001N1Esfahan University of Medical Sciences210
尚未招募
3 期
Comparison the Effect of Empaglifluzin and Linagliptin on the Albuminuria of diabetic patientsIRCT20200722048176N1Arak University of Medical Sciences60
招募中
不适用
Comparison the effects of Empaglifluzin-linagliptin and Dapaglifluzin-linagliptin on HbA1c ? LDL and Albuminuria in patients with T2DMType 2 diabetes.IRCT20221221056889N1Arak University of Medical Sciences70